Dongxian Guan

1.5k total citations
17 papers, 891 citations indexed

About

Dongxian Guan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dongxian Guan has authored 17 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Dongxian Guan's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Research and Treatments (3 papers) and Cancer Cells and Metastasis (3 papers). Dongxian Guan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Research and Treatments (3 papers) and Cancer Cells and Metastasis (3 papers). Dongxian Guan collaborates with scholars based in China, United States and Singapore. Dongxian Guan's co-authors include Dong Xie, Yuezhen Deng, Jinɡjinɡ Li, Shuqun Cheng, Jiang‐Sha Zhao, Xiao‐Fan Wang, Yuanyuan Feng, Lingyun Long, Lin Qiu and Umut Özcan and has published in prestigious journals such as Nature Medicine, Nature Communications and Immunity.

In The Last Decade

Dongxian Guan

17 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongxian Guan China 14 503 255 250 154 109 17 891
Cuiling Qi China 19 545 1.1× 346 1.4× 296 1.2× 163 1.1× 39 0.4× 44 1.1k
Zhongguang Luo China 17 670 1.3× 277 1.1× 265 1.1× 127 0.8× 61 0.6× 39 1.1k
Sarah Yoon South Korea 15 574 1.1× 180 0.7× 286 1.1× 118 0.8× 55 0.5× 22 918
Qian Yan China 18 628 1.2× 283 1.1× 342 1.4× 172 1.1× 103 0.9× 66 1.1k
Xuequan Yao China 20 494 1.0× 313 1.2× 305 1.2× 145 0.9× 33 0.3× 37 921
Shuang Lin China 15 442 0.9× 163 0.6× 255 1.0× 48 0.3× 67 0.6× 34 778
Shi Zuo China 14 484 1.0× 142 0.6× 221 0.9× 54 0.4× 174 1.6× 52 837
Weihua Ren China 20 661 1.3× 258 1.0× 409 1.6× 150 1.0× 93 0.9× 43 1.1k

Countries citing papers authored by Dongxian Guan

Since Specialization
Citations

This map shows the geographic impact of Dongxian Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongxian Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongxian Guan more than expected).

Fields of papers citing papers by Dongxian Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongxian Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongxian Guan. The network helps show where Dongxian Guan may publish in the future.

Co-authorship network of co-authors of Dongxian Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Dongxian Guan. A scholar is included among the top collaborators of Dongxian Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongxian Guan. Dongxian Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Guan, Dongxian, Yuqin Men, Mario Andrés Salazar Hernández, et al.. (2024). Central inhibition of HDAC6 re-sensitizes leptin signaling during obesity to induce profound weight loss. Cell Metabolism. 36(4). 857–876.e10. 9 indexed citations
2.
Herrema, Hilde, Dongxian Guan, Xudong Feng, et al.. (2022). FKBP11 rewires UPR signaling to promote glucose homeostasis in type 2 diabetes and obesity. Cell Metabolism. 34(7). 1004–1022.e8. 22 indexed citations
3.
Lan, Xi, Nan Wu, Litao Wu, et al.. (2020). The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p. Molecular Therapy — Nucleic Acids. 20. 468–479. 22 indexed citations
4.
Feng, Xudong, Dongxian Guan, Jae Won Choi, et al.. (2019). IL1R1 is required for celastrol’s leptin-sensitization and antiobesity effects. Nature Medicine. 25(4). 575–582. 105 indexed citations
5.
Feng, Xudong, et al.. (2019). Lipocalin 2 Does Not Play A Role in Celastrol-Mediated Reduction in Food Intake and Body Weight. Scientific Reports. 9(1). 12809–12809. 7 indexed citations
6.
Chen, Tianwei, Yanmei Yuan, Dongxian Guan, et al.. (2019). CHML promotes liver cancer metastasis by facilitating Rab14 recycle. Nature Communications. 10(1). 2510–2510. 33 indexed citations
7.
Li, Jingjing, Hongkun Yin, Dongxian Guan, et al.. (2018). Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis. British Journal of Cancer. 118(10). 1337–1348. 58 indexed citations
8.
Bao, Wen, Yuezhen Deng, Lingyun Long, et al.. (2016). Iron overload in hereditary tyrosinemia type 1 induces liver injury through the Sp1/Tfr2/hepcidin axis. Journal of Hepatology. 65(1). 137–145. 27 indexed citations
9.
Jiang, Hao, Ning Ma, Wentao Zhou, et al.. (2016). Triosephosphate isomerase 1 suppresses growth, migration and invasion of hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications. 482(4). 1048–1053. 48 indexed citations
10.
11.
Long, Lingyun, Yuezhen Deng, Dongxian Guan, et al.. (2014). Recruitment of Phosphatase PP2A by RACK1 Adaptor Protein Deactivates Transcription Factor IRF3 and Limits Type I Interferon Signaling. Immunity. 40(4). 515–529. 101 indexed citations
12.
Li, Nan, Wenjun Hu, Jie Shi, et al.. (2013). Roles of Fibroblast Growth Factor-inducible 14 in Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention. 14(6). 3509–3514. 9 indexed citations
13.
Wang, Zheng, Yuhui Jiang, Dongxian Guan, et al.. (2013). Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma Cells. PLoS ONE. 8(9). e72846–e72846. 45 indexed citations
14.
Zhang, Yang, Dongxian Guan, Jie Shi, et al.. (2013). All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer. Journal of Hepatology. 59(6). 1255–1263. 78 indexed citations
15.
Deng, Yuezhen, Zhengfa Mao, Lingyun Long, et al.. (2012). RACK1 Suppresses Gastric Tumorigenesis by Stabilizing the β-Catenin Destruction Complex. Gastroenterology. 142(4). 812–823.e15. 89 indexed citations
16.
Zhao, Jiang‐Sha, Wenjie Li, Di Ge, et al.. (2011). Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44. PLoS ONE. 6(6). e21419–e21419. 92 indexed citations
17.
Feng, Yuxiong, Tao Wang, Yuezhen Deng, et al.. (2010). Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. Hepatology. 53(2). 483–492. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026